Company news
Arno Therapeutics Inc news in 2016
Arno Therapeutics Inc's news releases, calls and decks from 2016, newest first.
Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders
December 21, 2016
Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update
November 14, 2016
Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update
August 22, 2016
Arno Completes $2.8 Million Private Placement
August 22, 2016
Arno Therapeutics Reports First Quarter 2016 Financial and Business Update
May 16, 2016
UCLA's Dr. Stuart Holden Interviewed by The Life Sciences Report
April 21, 2016
Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA®
April 19, 2016
Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
March 30, 2016
Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II
March 21, 2016
Arno Therapeutics Completes $7.4 Million Common Stock Financing
January 13, 2016